Oluic Stevan, Hassan Mohamed, El Labban Mohamad, Guleid Hussein, Wedzina Waclaw
Internal Medicine, Mayo Clinic Health System, Mankato, USA.
Hospital Medicine, Mayo Clinic Health System, Mankato, USA.
Cureus. 2024 Apr 3;16(4):e57514. doi: 10.7759/cureus.57514. eCollection 2024 Apr.
We report a case of an 84-year-old patient with Monoclonal Gammopathy of Undetermined Significance (MGUS) treated with multiple courses of antibiotics and steroids before being diagnosed with infection. It is known that MGUS affects both humoral and cellular immunity with impairment of antibody production, function of T-cells, natural killer (NK) cells, and dendritic cells. This case report demonstrates the need to consider patients with MGUS as immunocompromised and draws attention to the correlation between MGUS and infections. The delay in diagnosis exemplifies the importance of considering atypical pathogens and involving sub-specialists early in the treatment of infections in patients with a history of MGUS.
我们报告了一例84岁患有意义未明的单克隆丙种球蛋白病(MGUS)的患者,在被诊断出感染之前接受了多疗程的抗生素和类固醇治疗。已知MGUS会影响体液免疫和细胞免疫,损害抗体产生、T细胞、自然杀伤(NK)细胞和树突状细胞的功能。本病例报告表明,有必要将MGUS患者视为免疫功能低下者,并提请注意MGUS与感染之间的相关性。诊断延迟体现了在MGUS病史患者的感染治疗中考虑非典型病原体并尽早让专科医生参与的重要性。